Tarius, supporting regulatory intelligence and compliance in the healthcare industry, was sold to US IQVIA (listed on the New York Stock Exchange) in December 2017. infotransactions has acted as trusted advisor to the sellers in a structured sales process of global interest.
Tarius provides regulatory information from more than 100 countries on a user-friendly web-based platform. The information includes rules, regulations and guidelines of both national and international organisations concerning all phases of the life cycle of medical and pharmaceutical products. Using a global network of more than 300 local experts, Tarius is sure to provide accurate information which can form the basis of the customers’ activities and decisions.
infotransactions has acted as trusted advisor and partner to the sellers throughout the structured sales process where several prospective buyers showed interest.
”Tarius is an exciting company with global potential, and therefore we have also seen great interest from several potential buyers in the process. The dialogue with IQVIA has been really good and were are thus quite confident that they are the perfect future owners of Tarius,” says Bertel Maigaard of infotransactions.
By selling its activities to IQVIA, Tarius becomes part of a large global set-up which provides access to new markets and customers and even better chances of realising the company’s huge potential.
Ting tager tid, når man vil gøre dem ordentligt, og dét vil Niels Jacobsen. Han brugte flere år på at forberede både si…
inforevision er medlem af UHY - et netværk af uafhængige revisions- og rådgivningsvirksomheder i mere end 100 lande.…
Housing Denmark A/S oplever efterspørgsel på professionel rådgivning og praktisk assistance i forbindelse med udlejning af…